Bayer’s latest annual report shows the company had faced claims from over 13,000 patients, but has spent almost $1 billion so far to settle around 4,800 Yaz lawsuits alleging blood clot injuries.
Chicago, IL (PRWEB) May 16, 2013
The birth control safety center at DrugRisk.com is announcing new information on the site for women who have taken the contraceptives Yaz or Yasmin. A recent court update shows the number of cases filed alleging blood clots has fallen, as Bayer continues to settle claims*.
DrugRisk.com was created to improve patient safety by providing those taking popular prescription drugs with the latest research, safety alerts, recalls and litigation news. Visitors can determine if others have experienced similar side effects and decide if they need legal advice.
The resource center has added warnings from health experts like the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
After thousands of patients filed a Yaz lawsuit alleging blood clots, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
Bayer’s latest annual report shows the company had faced claims from over 13,000 patients, but has spent almost $1 billion so far to settle around 4,800 Yaz lawsuits alleging blood clot injuries like deep vein thrombosis (DVT) or pulmonary embolism, and will continue to evaluate new cases for settlement****.
Now, DrugRisk has added the latest update from the Judicial Panel on Multidistrict Litigation, which shows the number of filed claims has fallen to 9,961 from the 13,000 indicated by Bayer*.
Lawyers are still helping those who suffered a Yaz DVT, Pulmonary Embolism, Stroke or Blood Clot after taking the birth control. Anyone affected is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.
Due to the specialized nature of federal MDL drug injury litigation, DrugRisk cautions that patients should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*JPML 5/15/13; jpml.uscourts.gov/sites/jpml/files/Pending%20MDL%20Dockets_By%20District_May-14-2013.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer 2/28/13; annualreport2012.bayer.com/en/legal-risks.aspx